Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury.
Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury.
复制标题
DOI:
10.1016/j.surg.2009.06.011
复制
发表时间:
2009-08
期刊:
影响因子:
3.8
通讯作者:
Geller DA
中科院分区:
文献类型:
--
作者:
Kim KH;Dhupar R;Ueki S;Cardinal J;Pan P;Cao Z;Cho SW;Murase N;Tsung A;Geller DA
Liver ischemia and reperfusion (IR) injury is a phenomenon that leads to graft dysfunction following liver transplantation. Understanding the molecular mechanisms behind this process is crucial to developing strategies to prevent short and long term graft dysfunction. The purpose of this study is to explore the role of the transcription factor, IRF-1, in a model of orthotopic rat liver transplantation. Orthotopic syngeneic LEW rat liver transplantation (OLT) was performed after 18 or 3 hours preservation in cold UW solution. AdIRF-1 or control gene vector (Adnull) was delivered to the liver by donor intravenous pretreatment 4 days before graft harvesting. Uninfected grafts also served as controls. Recipients were sacrificed 1 to 24 hours post-transplantation. Rats that underwent OLT with long-term preserved graft (18 hours) displayed increased hepatic nuclear expression of IRF-1 protein at 1 and 3 hours. Rats pre-treated with AdIRF-1 prior to transplantation had increased ALT levels and increased expression of IFN-β, IFN-γ, IL-12, and iNOS in short-term period graft(3 hours) when compared with donor livers pre-treated with Adnull. AdIRF-1 pre-treated donor livers also exhibited increased susceptibility to early apoptosis in the transplanted grafts with increased TUNEL staining expression of cleaved caspase-3. Additionally, AdIRF-1 pre-treated donor livers had increased activation of the MAP kinase JNK as compared with Adnull pre-treated donor livers. IRF-1 is an important regulator of IR injury after OLT in rats. Targeting of IRF-1 may be a potential strategy to ameliorate ischemic liver injury after transplantation in order to minimize organ dysfunction.
登录
查看更多内容
影响因子:
6.2
作者:
Mueller, THJ;Kienle, K;Rentsch, M
通讯作者:
Rentsch, M
影响因子:
11.4
作者:
PINE, R;CANOVA, A;SCHINDLER, C
通讯作者:
SCHINDLER, C
DOI:
10.1073/pnas.90.8.3491
发表时间:
1993-04-15
影响因子:
11.1
作者:
GELLER, DA;LOWENSTEIN, CJ;BILLIAR, TR
通讯作者:
BILLIAR, TR
影响因子:
6.2
作者:
Chia, SH;Geller, DA;Murase, N
通讯作者:
Murase, N
影响因子:
6.2
作者:
FURUKAWA, H;TODO, S;STARZL, TE
通讯作者:
STARZL, TE